phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Drug Withdrawal Symptoms

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Drug Withdrawal Symptoms in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (88.89)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH; Raoof, H; Silberring, J; Suder, P	1
Allard, M; Gold, L; Simonnet, G; Stinus, L	1
Blossman, JB; Burgess, K; Lake, JR; Lawless, BA; Malin, DH; Sailer, EE; Schopen, CK; Short, PE; Wilson, OB	1
Claunch, AE; Ho, KK; Jones, JA; Lake, JR; Liu, J; Malin, DH; Morel, J; Payza, K; Smith, DA; Stevens, PA	1
Claunch, AE; Corbit, BP; Jones, JA; Kacher, D; Lake, JR; Malin, DH; Moon, WD; Morel, J; Smith, DA; Stevens, PA; Webb, SL	1
Francés, B; Gelot, A; Gicquel, S; Zajac, JM	1
Harris, KH; Jhamandas, JH; Jhamandas, KH; Petrov, T; Yang, HY	1
Chen, JC; Huang, EY; Li, JY; Liang, KW; Tan, PP; Wong, CH	1
Dougherty, TM; Fowler, DE; Hammond, MV; Lake, JR; Leyva, JE; Ludgate, K; Malin, DH; Rogillio, RB; Sloan, JB	1

Reviews

1 review(s) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Drug Withdrawal Symptoms

Article	Year
FMRF-NH2 like mammalian octapeptide in opiate dependence and withdrawal. NIDA research monograph, 1990, Volume: 105 Topics: Animals; FMRFamide; Humans; Neuropeptides; Neurotransmitter Agents; Oligopeptides; Opioid-Related Disorders; Substance Withdrawal Syndrome	1990

Other Studies

8 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Drug Withdrawal Symptoms

Article	Year
Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats. Peptides, 2012, Volume: 33, Issue:1 Topics: Adamantane; Amphetamine; Animals; Anxiety; Behavior, Animal; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Male; Maze Learning; Oligopeptides; Rats; Rats, Wistar; Receptors, Neuropeptide; Substance Withdrawal Syndrome	2012
Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides, 1995, Volume: 16, Issue:7 Topics: Adaptation, Biological; Animals; Central Nervous System; Drug Tolerance; Models, Biological; Morphine; Naloxone; Neuropeptides; Oligopeptides; Opioid-Related Disorders; Pain Threshold; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1995
Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF. Pharmacology, biochemistry, and behavior, 1996, Volume: 54, Issue:3 Topics: Amino Acid Sequence; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Molecular Sequence Data; Narcotic Antagonists; Neuropeptides; Nicotine; Nicotinic Agonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1996
Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Drug and alcohol dependence, 1995, Volume: 40, Issue:1 Topics: Animals; Dansyl Compounds; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Neurologic Examination; Oligopeptides; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Substance Withdrawal Syndrome	1995
Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF. Peptides, 1996, Volume: 17, Issue:4 Topics: Animals; Arginine; Cerebral Ventricles; Enzyme Inhibitors; Injections, Intraventricular; Male; Narcotic Antagonists; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Rats; Rats, Sprague-Dawley; Stereoisomerism; Stereotyped Behavior; Substance Withdrawal Syndrome	1996
Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice. European journal of pharmacology, 1998, Oct-09, Volume: 358, Issue:3 Topics: Amino Acid Sequence; Animals; Brain; Drug Tolerance; Humans; Injections, Intraventricular; Male; Mice; Morphine; Morphine Dependence; Narcotic Antagonists; Narcotics; Oligodeoxyribonucleotides, Antisense; Oligopeptides; Substance Withdrawal Syndrome	1998
Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal. The Journal of comparative neurology, 1998, Dec-14, Volume: 402, Issue:2 Topics: Angiotensin II; Animals; Hemodynamics; Hypertension; Hypotension; Male; Morphine; Morphine Dependence; Naloxone; Neurons; Nitroprusside; Oligopeptides; Phenylephrine; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Solitary Nucleus; Substance Withdrawal Syndrome	1998
Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs. Peptides, 1999, Volume: 20, Issue:10 Topics: Animals; Molecular Structure; Morphine; Naloxone; Narcotic Antagonists; Neuropeptides; Oligopeptides; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tetrahydroisoquinolines	1999